Case–Control Study of Cutaneous Human Papillomaviruses in Squamous Cell Carcinoma of the Skin

Background: Cutaneous human papillomavirus (HPV) infection may be a risk factor for squamous cell carcinoma (SCC) of the skin. Methods: To investigate the association between cutaneous HPV and SCC, a case–control study was conducted, including 173 SCC cases from a university dermatology clinic and 300 controls that screened negative for skin cancer. Serum antibodies against cutaneous HPV types in genera alpha, beta, gamma, mu, and nu were measured. Tumor tissue from 159 SCC cases was tested for the presence of DNA for genus-beta HPV types. Using logistic regression ORs and 95% confidence intervals (CI) were estimated for the associations between SCC and cutaneous HPV infection, adjusting for age and sex. The Bonferroni method was used to account for multiple comparisons. Results: SCC was positively associated with seropositivity to any genus-beta HPV type (OR, 1.93; 95% CI, 1.23–3.02), particularly with types in species-1 (OR, 1.86; 95% CI, 1.22–2.85). Type-specific associations with SCC were observed for HPV 8 (OR, 1.80; 95% CI, 1.14–2.84), 17 (OR, 1.59; 95% CI, 1.02–2.49) and HPV 10 from genus-alpha (OR, 2.24; 95% CI, 1.04–4.85). None of the type-specific associations remained statistically significant after correction for multiple comparisons. When DNA-positive SCC cases were compared with controls, strong serologic associations were observed for HPVs 5 (OR, 3.48; 95% CI, 1.27–9.59), 17 (OR, 3.36; 95% CI, 1.29–8.72), and 24 (OR, 3.79; 95% CI, 1.24–11.5). Conclusion: Genus-beta HPV infections were associated with SCC in our study population. Impact: Identifying the role of cutaneous HPV infection in SCC may lead to improved characterization of high-risk individuals and the development of novel prevention strategies. Cancer Epidemiol Biomarkers Prev; 21(8); 1303–13. ©2012 AACR.

[1]  V. Sondak,et al.  Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin. , 2012, The Journal of infectious diseases.

[2]  V. Sondak,et al.  Case–control Study of Merkel Cell Polyomavirus Infection and Cutaneous Squamous Cell Carcinoma , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[3]  A. Kopp-Schneider,et al.  E6 and E7 from Beta Hpv38 Cooperate with Ultraviolet Light in the Development of Actinic Keratosis-Like Lesions and Squamous Cell Carcinoma in Mice , 2011, PLoS pathogens.

[4]  M. Pawlita,et al.  The Association between Cutaneous Squamous Cell Carcinoma and Betapapillomavirus Seropositivity: a Cohort Study , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[5]  L. Naldi,et al.  Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. , 2010, Cancer research.

[6]  A. Storey,et al.  Cutaneous HPV5 E6 causes increased expression of Osteoprotegerin and Interleukin 6 which contribute to evasion of UV-induced apoptosis. , 2010, Carcinogenesis.

[7]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[8]  M. Karagas,et al.  Genus β human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study , 2010, BMJ : British Medical Journal.

[9]  E. de Villiers,et al.  Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. , 2010, Virology.

[10]  A. Giuliano,et al.  Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida. , 2010, The Journal of infectious diseases.

[11]  M. Pawlita,et al.  Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. , 2009, The Journal of general virology.

[12]  V. Sondak,et al.  Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers , 2008, International journal of cancer.

[13]  M. Simmonds,et al.  Identification of the regions of the HPV 5 E6 protein involved in Bak degradation and inhibition of apoptosis , 2008, International journal of cancer.

[14]  M. Pawlita,et al.  Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin , 2008, The British journal of dermatology.

[15]  M. Pawlita,et al.  Seroprevalence of 34 Human Papillomavirus Types in the German General Population , 2008, PLoS pathogens.

[16]  J. Marvel,et al.  Loss of p53 or p73 in human papillomavirus type 38 E6 and E7 transgenic mice partially restores the UV-activated cell cycle checkpoints , 2008, Oncogene.

[17]  J. Dillner,et al.  Seroreactivity to Cutaneous Human Papillomaviruses among Patients with Nonmelanoma Skin Cancer or Benign Skin Lesions , 2008, Cancer Epidemiology Biomarkers & Prevention.

[18]  T. Key,et al.  A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition , 2007, International journal of cancer.

[19]  J. Dillner,et al.  Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. , 2007, The Journal of infectious diseases.

[20]  S. Franceschi,et al.  Development of a Sensitive and Specific Multiplex PCR Method Combined with DNA Microarray Primer Extension To Detect Betapapillomavirus Types , 2007, Journal of Clinical Microbiology.

[21]  R. Neale,et al.  Re: Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. , 2006, Journal of the National Cancer Institute.

[22]  S. Franceschi,et al.  Development of a Sensitive and Specific Assay Combining Multiplex PCR and DNA Microarray Primer Extension To Detect High-Risk Mucosal Human Papillomavirus Types , 2006, Journal of Clinical Microbiology.

[23]  M. Karagas,et al.  Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. , 2006, Journal of the National Cancer Institute.

[24]  A. Green,et al.  Markers of Cutaneous Human Papillomavirus Infection in Individuals with Tumor-Free Skin, Actinic Keratoses, and Squamous Cell Carcinoma , 2006, Cancer Epidemiology Biomarkers & Prevention.

[25]  M. Pawlita,et al.  Suppression of non-specific binding in serological Luminex assays. , 2006, Journal of immunological methods.

[26]  Zhao-Qi Wang,et al.  Skin Hyperproliferation and Susceptibility to Chemical Carcinogenesis in Transgenic Mice Expressing E6 and E7 of Human Papillomavirus Type 38 , 2005, Journal of Virology.

[27]  Markus F Templin,et al.  Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. , 2005, Clinical chemistry.

[28]  R. Saladi,et al.  The causes of skin cancer: a comprehensive review. , 2005, Drugs of today.

[29]  H. van Loveren,et al.  Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus. , 2004, The Journal of investigative dermatology.

[30]  W. Sterry,et al.  Human Papillomaviruses in Transplant‐Associated Skin Cancers , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[31]  P. Fuchs,et al.  High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population , 2003, Archives of Dermatological Research.

[32]  O. Forslund,et al.  A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non‐melanoma skin cancers and solar keratosis , 2003, The British journal of dermatology.

[33]  R. Westendorp,et al.  Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. , 2003, Cancer research.

[34]  E. de Villiers,et al.  The E6 and E7 Proteins of the Cutaneous Human Papillomavirus Type 38 Display Transforming Properties , 2003, Journal of Virology.

[35]  M. Pawlita,et al.  HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. , 2002, Journal of virological methods.

[36]  V. de Waard,et al.  Transduction of the E6 and E7 genes of epidermodysplasia-verruciformis-associated human papillomaviruses alters human keratinocyte growth and differentiation in organotypic cultures. , 2001, The Journal of investigative dermatology.

[37]  M. Pawlita,et al.  A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. , 2001, Journal of immunological methods.

[38]  Miranda Thomas,et al.  Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. , 2000, Genes & development.

[39]  J. McGregor,et al.  Human papillomavirus infection and non‐melanoma skin cancer in immunosuppressed and immunocompetent individuals , 2000, Journal of medical virology.

[40]  A. Storey,et al.  E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage , 2000, Oncogene.

[41]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[42]  G. Orth,et al.  Human papillomaviruses associated with epidermodysplasia verruciformis. II. Molecular cloning and biochemical characterization of human papillomavirus 3a, 8, 10, and 12 genomes , 1983, Journal of virology.